ebook: Maximizing preclinical confidence in target efficacy and safety

This ebook outlines Euretos’ approach to target discovery and indication expansion. Whilst also discussing data-driven target selection.

With over 70% of failures in the clinical stage attributed to the choice of drug target, preclinical target selection is the most impactful step in drug development. Therefore, this eBook is dedicated to covering the following topics: 

  •  How Euretos has contributed to real world results for five different biopharma clients, including approved drugs and active clinical trials in oncology, Sjogren’s disease, Ulcerative Colitis, NASH and epilepsy
  • How computational disease models predict novel gene-disease associations
  • A case study: Target Discovery for Rheumatoid Arthritis
  • The benefits of using an AI-integrated knowledge graph for target assessment.